Plain-English translation of NCT06232395 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a new blood test to find stomach cancer earlier and monitor patients after surgery. Instead of relying only on imaging scans and current blood markers, this study will compare new biomarkers found in blood samples to see if they can spot cancer or cancer recurrence sooner and more accurately.
Current methods to detect stomach cancer and watch for it coming back after surgery are not always reliable or fast enough. This treatment aims to give doctors an earlier warning sign through a simple blood test, which could help patients get treated sooner when outcomes are better.
You likely qualify if…
You likely don't qualify if…
If you have stomach cancer or are in the healthy comparison group, you will have blood drawn at the study center. If you are having surgery for stomach cancer, you will also have blood collected at different time points after your operation to track whether the new blood test can detect any cancer coming back. The study will follow you over time to see how well this new blood test works compared to standard methods.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
China
Collaborators
Fudan University
Enrollment target
~1,197 participants
Started
February 2024
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.